Building a Better Market Pathway: Aligning Regulatory, Reimbursement and Commercialization Teams

Most medtech teams underestimate the work before FDA submission—and overestimate what happens after clearance. In this episode, regulatory expert Michelle Lott, commercialization strategist Renae Franz, and reimbursement specialist Fernanda Nusbaum unpack the leadership blind spots, strategic missteps, and easily avoidable financial risks that derail medtech companies every day. You’ll learn why regulatory, reimbursement, and commercial strategy must be developed in parallel; how misaligned claims create expensive detours; what payers actually look for (hint: not FDA clearance); when coding fails; how reimbursement timelines stretch into years; and how to pick the right regulatory pathway without blowing your budget. Packed with real examples—including companies that lost funding because they misunderstood CPT codes and companies that reached market faster by stair-stepping claims—this episode gives founders, CEOs, and RA/QA leaders a roadmap for reducing rework, avoiding FDA surprises, and accelerating revenue.

You can listen to Building a Better Market Pathway: Aligning Regulatory, Reimbursement and Commercialization Teams online on Radio and Podcast. Open the player on this page to stream the available audio.

Building a Better Market Pathway: Aligning Regulatory, Reimbursement and Commercialization Teams is an episode from RA/QA Today by RAQA Today.

This episode is 00:40:53 long.

This episode was published on Dec 8, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from RA/QA Today when more episodes are available from the podcast feed.